INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
02/17/2026
Back to search
Official data from USPTO
SVAR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079241657Class
1, 5, 9, 10, 38, 42, 44
Filing
79241657
Registration
5736546
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
04/03/2026
Trademark type
Combined
Nice classes
1, 5, 9, 10, 38, 42, 44
Filing date
05/11/2018
Registration date
04/30/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/17/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
708
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
Malmö, SE
Examiner
SHEN, ELIZABETH S
Current location
Historical data usage
Holders and representatives
Holders
SVAR Life Science AB
Euro-Diagnostica AB
Representatives
Maurine Knutsson Knutsson IP AB
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10Class 38Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Substances for use in cell-based reporter gene assaysassays for research purposes; reagents for medical research purposes; reagents for research purposes; reagents for industrial purposesreagents for scientific and research use; reagents for chemical analyseschemical reagents for non-medical purposes; cells and reagents for scientific and research use in testing of pharmaceutical products; cell culture media for scientific and research usecell-lines; components for cell-based analyses using optical methods and containing chemical reagentscells for scientific and research use; chemical preparations for the laboratory and for scientificdiagnostic and analytical purposesother than for medical or veterinary use
Class 5
Reagents for medical use; diagnostic reagents for medical use; biological reagents for medical use; medical diagnostic reagents and assays for testing of body fluids; diagnostic and analytical substances for medical and veterinary purposesin particularlaboratory diagnostic kits comprised of medical diagnostic reagentsanti-bodiesimmunochemicals for use in disease detection in the area of medical prevention
Class 9
Instruments for use in performing cell-based assays by means of optic detectionoptical inspection apparatus; computer software for use in performing optic based biological analysis; computer software for use in performing optic based biological analysisfor using tools during drug developmentclinical diagnosisclinical monitoring or assay development; computer application software for mobile phones and handheld computerssoftware for patient monitoring; apparatus for recordingtransmission and reproduction of sound and images; blank magnetic data carriers; digital recording mediablank digital storage media
Class 10
Medical diagnostic apparatus for testing assays; medical equipmentapparatus for analysing blood
Class 38
Telecommunication servicestransmission of voicedatagraphicsimagesaudio and video by means of telecommunications networkswireless communication networksthe Internet; providing access to portals on the internet
Class 42
Cell-based assay servicescustom design and development of cell-based biochemical assays; cell-based assay servicescustom design and development of cell-based biochemical assays for use in drug developmentclinical diagnosisclinical monitoring or assay development; medical research; clinical research in the field of drug developmentclinical diagnosisclinical monitoring or assay development; scientific research; research and development in the field of diagnostic preparations; pharmaceutical drug development services; conducting clinical trials for others; laboratory research and analysis services in the field of drug developmentclinical diagnosisclinical monitoring or assay development; scientific laboratory testing services; research in the fields of medicine and data analytics; providing scientific diagnostic services for others in the fields of drug developmentclinical diagnosisclinical monitoring or assay development ; testing of chemical preparations and cells for diagnostic purposes
Class 44
Medical testing services relating to measurement and quantification of drug levels and immunogenicity in patient samples for diagnostic or treatment purposes ; medical servicestreating persons based on laboratory analysis; providing medical support in the nature of medical monitoring of patients receiving medical treatments; medical diagnostic testing services
Publications
History of USPTO decisions and trademark events.
39 publications found
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
06/17/2025
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
06/17/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/16/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/07/2025
ES75
TEAS SECTION 71 & 15 RECEIVED
02/25/2025
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
06/05/2020
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
04/15/2020
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
04/02/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/13/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/26/2019
FIMP
FINAL DISPOSITION PROCESSED
08/26/2019
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
08/15/2019
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
08/15/2019
PLGL
ASSIGNED TO PARALEGAL
08/15/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/30/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
04/30/2019
PUBO
PUBLISHED FOR OPPOSITION
02/12/2019
GPNX
NOTIFICATION PROCESSED BY IB
02/08/2019
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
02/01/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/23/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/23/2019
NPUB
NOTICE OF PUBLICATION
01/23/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/03/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/29/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/28/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/28/2018
RFNT
REFUSAL PROCESSED BY IB
11/09/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/23/2018
RFRR
REFUSAL PROCESSED BY MPU
10/23/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/12/2018
CNRT
NON-FINAL ACTION WRITTEN
10/11/2018
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
10/11/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/11/2018
CNRT
NON-FINAL ACTION WRITTEN
10/10/2018
MAFR
APPLICATION FILING RECEIPT MAILED
10/09/2018
DOCK
ASSIGNED TO EXAMINER
10/03/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/03/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/27/2018
Continuous trademark protection
Get notified about every new filing that threatens SVAR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.